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ABSTRACT In this work, we performed simulations to develop and test a strategy for exploiting surrogate
sire technology in animal breeding programs. Surrogate sire technology allows the creation of males that
lack their own germline cells, but have transplanted spermatogonial stem cells from donor males. With this
technology, a single elite male donor could give rise to huge numbers of progeny, potentially as much as all
the production animals in a particular time period. One hundred replicates of various scenarios were
performed. Scenarios followed a common overall structure but differed in the strategy used to identify elite
donors and how these donors were used in the product development part. The results of this study showed
that using surrogate sire technology would significantly increase the genetic merit of commercial sires, by as
much as 6.5 to 9.2 years’ worth of genetic gain compared to a conventional breeding program. The
simulations suggested that a strategy involving three stages (an initial genomic test followed by two sub-
sequent progeny tests) was the most effective of all the strategies tested. The use of one or a handful of elite
donors to generate the production animals would be very different to current practice. While the results
demonstrate the great potential of surrogate sire technology there are considerable risks but also other








In this study, we performed simulations to develop a strategy for
exploiting surrogate sire technology (Oatley 2017; Park et al. 2017) in
animal breeding programs (Figure 1). Surrogate sire technology allows
the creation of males that lack their own germline cells, but have trans-
planted spermatogonial stem cells from other donor males. The con-
cept requires the production of recipient males with an ablated germ
line. Rodent males can have their germline ablated using chemotoxic
drugs or localized irradiation of the testes, but, importantly for use in
livestock breeding, this ablation is incomplete and recipient sperm out-
put is mixture of donor and recipient cells (Zhang et al. 2006). The
mammalian NANOS2 gene seems to be absolutely required for the
maintenance of germ line cells in males only (Tsuda et al. 2003). In
mice, Nanos 2 knock out males the testes completely lack germ-line
cells, but there is no effect in females (Tsuda et al. 2003). NANOS
2 knock out pigs have been produced using CRISP/Cas9 gene editing
(Park et al. 2017) and boars homozygous for the knockout likely pro-
vide ideal recipients for the surrogate sire concept.”
With this technology, a single elitemaledonor could give rise tohuge
numbers ofprogeny,potentiallyasmuchas all theproductionanimals in
a particular time period. This potential offers many advantages. First, it
would reduce the genetic lag between the elite nucleus animals and the
production animals. Second, it could enable better matching of specific
management plans to the genetics. Third, as we outline in the discussion
it could enable exploitation of combining ability. The latter could
increase production on farm and increase investment and innovation
in breeding by enabling a greater ability to protect intellectual property.
Typically, animal breeding programs are implicitly or explicitly
organized in pyramid structures with layers (Figure 2). The top layer
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is the nucleus, which is improved using recurrent selection. Nowadays
most selection decisions are made using genomic based testing rather
than traditional phenotype based testing(Tsuda et al. 2003; De Roos
2011; Pryce andDaetwyler 2012;Meuwissen et al. 2013; Van Eenennaam
et al. 2014; Knol et al. 2016) . The middle layer is the multiplication,
where the nucleus genetics is multiplied and sometimes crosses between
purebred lines are produced. The base layer is the commercial sector,
where the majority of animals are kept for production. The commercial
producers oftenmake a final cross between the terminal line sires and the
maternal line dams.
The need to generate huge numbers of production animals and the
limited number of progeny that a male can produce means that large
numbers of nucleus animals must contribute genetics to the subsequent
layers and that one to several generations are required for multiplication.
These factorsgive rise toagenetic lag, adifference ingeneticmeanbetween
the nucleus and commercial layers. This lag can also be represented with
the number of years of genetic gain (Visscher et al. 2000), e.g.,4 years in
a pig breeding program. Surrogate sire technology would allow a single
elite nucleus male to give rise to very large numbers of commercial
animals, by donating spermatogonial stem cells to its commercial surro-
gates (Park et al. 2017). This could shorten the lag between the nucleus,
multiplication, and commercial layers.
Using surrogate sire technology in this way would require that animal
breeding programs identify elite donor males and create surrogate sires.
Thisprocess should takeplace inasufficiently small amountof timesothat
the extra genetic gainwould not be significantly reduced by the extra time
required for the identification of donors and creation of surrogate sires.
A restructured animal breeding program with surrogate sire tech-
nology would be conceptually similar to a plant breeding program that
produces clonally propagated individual lines or inbred lines or hybrid
lines (Figure 2). These programs seek: (i) to identify the best individual
(note: here we take individual tomean clonal, inbred or hybrid lines), or
a handful of individuals, from a population of individuals; and (ii) to
disseminate this individual very widely in the commercial layer
(Bernardo 2014). To identify the best individual, plant breeders typi-
cally use multiple stage testing and selection. As the breeding program
progresses through these stages the number of individuals being tested
is reduced and the precision of these tests increases. The small number
of individuals in the final stages are intensively tested in large replicated
experiments that are repeated across several environments and years.
This ensures that the commercially released individual is well charac-
terized and carries aminimal risk ofmajor undetected weakness. This is
necessary because this individual will have a huge footprint in the
commercial layer. Similar levels of evaluation would be needed with
surrogate sire technology in animal breeding programs.
The objective of this study was to develop a strategy for exploiting
surrogate sire technology in animal breeding programs. This strategy
involvedasubtle,but important, reorganization tocombinecomponents
of traditional animalandplantbreedingprograms.Thereorganization is
similar to the two-part breeding program that we recently proposed for
Figure 1 Schematic depicting the
possible application of spermatogo-
nial stem cell transplantation method-
ology in pig production (depiction
inspired by Oatley et al., 2017).
Figure 2 Example animal (left) and
plant (right) breeding schemes.
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the incorporation of genomic selection into plant breeding programs
(Gaynor et al. 2017). The reorganization involves an explicit partitioning
of a breeding program into a population improvement component and a
product development component. The population improvement com-
ponent is similar to the currently used recurrent genomic selection in
many animal breeding nucleus populations. The product development
component is similar to traditional plant breeding programs and in-
volves a number of stages of testing to identify the elite donors. The
product development component could make use of testing for combin-
ing ability, if that was appropriate for the particular species of interest.
With a focus on application in pig breeding, several alternative
versionsof the reorganizedbreedingprogramwere compared todifferent
variants of a conventional breeding program using simulation. The
alternative versions varied: (i) the number of stages of testing; (ii) the
numberof donor candidates tested at subsequent stages; (iii) the accuracy
of the genomic test at the first stage; and (iv) the accuracy of progeny test
in later stages. The results showed that using surrogate sire technology
would significantly increase the genetic merit of commercial sires, by as
much as between 6.5 and 9.20 years’ worth of genetic gain compared to
different variants of a conventional breeding program. The simulations
suggested that an identification strategy involving three stages (a geno-
mic test followed by two subsequent progeny tests) was the most effec-
tive of all the strategies tested. The use of one or a handful of elite donors
to generate the production animals would be very different to current
practice. While the results demonstrate the great potential of surrogate
sire technology there are considerable risks and these are discussed.
METHODS
Simulation was used to evaluate the impact of a strategy for exploiting
surrogate sire technology in animal breeding programs. One hundred
replicates of various scenarios were performed. Scenarios followed a
common overall structure but differed in the strategy used to identify
elite donors and how these donors were used (Figure 3, 4).
Conceptually, the simulation schemewas divided into historical and
future phases. The historical phase represented historical evolution and
recent animal breeding efforts up to the present day, under the assump-
tion that animal populations have evolved for tens of thousands of years,
followed by 22 recent generations of modern animal breeding with
selectionongenomicbreedingvalues inanucleuspopulation.The future
phase represented 20 future generations of modern animal breeding,
with selection on genomic breeding values in a nucleus population that
subsequently supplied genetic improvement to multiplication and
commercial layers. The historical animal breeding generations were
denoted -21 to 0 and the future animal breeding generations were
denoted1 to20.Themultiplierandcommercial layerswerenot explicitly
simulated butwere instead representedwith the average geneticmerit of
nucleus males that would give rise to multiplication and commercial
animals while accounting for the time lag. Specifically, we only focused
on a breeding program that produced terminal males in a scheme that
closely resembled a pig breeding program.
Simulations involved the following four steps:
i. Generating genome,
ii. Generating a quantitative trait and breeding values,
iii. Generating an animal breeding program,
iv. Selection and dissemination to the commercial layer with the
conventional or surrogate sires strategy.
Results are presented as themean of one hundred replicates for each
scenario and encompass the genetic merit of nucleus males that would
give rise to commercial animals at a given time point.
Genome
Whole-genome sequences were generated using the Markovian
Coalescent Simulator (MaCS) (Chen et al. 2009) and AlphaSim
(Faux et al. 2016) for 400 base haplotypes for each of ten 10 chromo-
somes. Chromosomes (each 100 cM long and comprising 108 base
pairs) were simulated using a per site mutation rate of 2.5·1028, a per
site recombination rate of 1.0·1028, and an effective population size
(Ne) that varied over time in accordance with estimates that are
representative of livestock populations (Hayes et al. 2003; Hill 2009;
Brotherstone and Goddard 2005; Rodríguez-Ramilo et al. 2015) as
follows: Ne was set to 100 in the final generation of the coalescent
simulation, to Ne = 1256, 1000 years ago, to Ne = 4350, 10,000 years
ago, and to Ne = 43,500, 100,000 years ago, with linear changes in
between these time-points. The resulting sequences had approxi-
mately 540,000 segregating sites.
Quantitative trait
A quantitative trait was simulated by randomly sampling 10,000 causal
loci from the genome in the base population, with the restriction that
1,000were sampled fromeachof the10chromosomes. For these loci, the
allele substitution effect was randomly sampled from a normal distri-
butionwithameanof0andstandarddeviationof0.01(1.0dividedby the
square root of the number of loci).
Breeding values
True breeding valueswere computed as a sumof effects at causal loci. To
simulate selection without the full computational burden and complex-
ity of simulating training sets and estimation with best linear unbiased
prediction,wesimulatedpseudoestimatesofbreedingvaluesbyaddinga
level of noise to truebreeding values.Different levels of noisewere added
to achieve a targeted accuracy. For the genomic tests we simulated
accuracies of 0.50, 0.70 and 0.90. For the progeny tests we simulated
accuracies as a function of the number of progeny (Mi et al. 2014) used
in the different scenarios (described below).
Breeding program
A pedigree of 42 generations for the nucleus population was simulated.
Each generation included 1,000 (SmallScenario) or 5,000 (BigScenario)
individuals with equal sex ratio. The different numbers of individuals
were used to quantify impact of nucleus population size on the benefit of
surrogate sire technology.All females(500for theSmallScenarioor2,500
for the BigScenario) and 50 males were selected as the parents of each
generation. This selection was based on a genomic test. In the first
generation of the recent historical animal breeding population (i.e.,
generation -22), the chromosomes of each individual were sampled
from the 400 base haplotypes. In later generations (i.e., generations
-21 to 20), the chromosomes of each individual were sampled from
parental chromosomes with recombination (assuming no interfer-
ence). A recombination rate of 1 Morgan per chromosome was used,
resulting in a 10 Morgan genome.
Scenarios
Two different strategies were used to identify males from the nucleus
whowould give rise to commercial animals, either through conventional
multiplication or surrogate sires. The conventional multiplication strat-
egy used the top 50, 200, or 500males in both the SmallScenario and the
BigScenario. Males were chosen based on a genomic test. The surrogate
sires strategy used multi-stage testing. Males were chosen based on an
initialgenomic test (S0), followedbyoneor twosubsequentprogenytests
(S1 and S2). As is the case with plant breeding programs, as the testing
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progressed through the stages we reduced the number of tested indi-
viduals and increased accuracy of tests. Based on the tests the best
individual or set of individualswere identifiedandused as elite donors of
spermatogonial stem cells to surrogate sires.
To quantify the impact of different amounts of testing resources and
different allocation of these resources we simulated different accuracies
of the genomic test at S0, different numbers of donor candidates tested
with different number of progeny at S1 and S2. At S0 we simulated a
genomic testwithanaccuracyof 0.50, 0.70, and0.90. To ensure that each
breeding program had the same costs, we assumed that a total of 14,000
progeny were available for progeny testing stages.
With single progeny test (S1) we used the 14,000 progeny to test
14 donor candidates eachwith 1,000 progeny, 28 donor candidates each
with500progeny,56donorcandidateseachwith250progeny,112donor
candidates each with 125 progeny, 224 donor candidates each with
63 progeny, or 448 donor candidates each with 31 progeny.
With two progeny tests (S1 and S2) we used either 2,000, 4,000, or
6,000 progeny for the first test (S1) and the remaining 12,000, 10,000,
or 8,000 for the second test (S2). At S1 either 100, 200, or 400 donor
candidates were tested. Thus, when 2,000 progeny were used at S1 the
100, 200, or 400 donor candidates were each tested with 20, 10, or
5progenyrespectively.When4,000progenywereusedatS1 the100,200,
Figure 4 Map of the scenarios used in
the study.
Figure 3 Timeline of the different strategies to
identify and disseminate genetic improvement.
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or 400 donor candidates were each tested with 40, 20, or 10 progeny
respectively. When 6,000 progeny were used at S1 the 100, 200, or
400 donor candidates were each tested with 60, 30, or 15 progeny
respectively. At S2 we tested either 10 or 20 donor candidates advanced
from S1. When 12,000 progeny remained to be used at S2 the 10 or
20 donor candidates were each tested with 1,200 or 600 progeny re-
spectively. When 10,000 progeny remained to be used at S2 the 10 or
20 donor candidates were each tested with 1,000 or 500 progeny re-
spectively. When 8,000 progeny remained to be used at S2 the 10 or
20donorcandidateswereeachtestedwith800or400progenyrespectively.
From each of these testing strategies we chose either 1 or 5 donors of
spermatogonial stem cells for surrogate sires in the commercial layer.
All of these different factors (two sizes of a breeding program [Small,
Big], three conventional strategy scenarios [50, 200, 500 males], six
surrogate sires strategy scenarios with two-stage testing, 18 surrogate sires
strategy scenarios with three-stage testing, and using one or five donors)
gave 102 different scenarios for each level of genomic test accuracy. The
map of all these scenarios and used resources is summarized in Figure 4.
Time assumptions
The time taken to transfer germplasm from the nucleus to the com-
mercial layer was assumed to be 3.5 years for the conventional strategy
(but see the note belowabout “dilution”), 3.5 years for the surrogate sires
strategy with two-stage testing, and 4.5 years for the surrogate sires
strategy with three-stage testing. The different steps that underlie these
time frames are presented in Figure 3.We based our parameters on pigs
and assumed 6 months for a male to reach sexual maturity, 4 months
for a successful gestation, and 8 months to collect terminal line phe-
notypes on progeny. Based on these parameters we assumed 12months
to progeny test a sexually mature male. When the donors are identified
we assumed that it takes a further 12months to produce surrogate sires
from these. Finally, we assumed a 12 months for the commercial prog-
eny to pass through gestation and complete their growth. We assumed
that the conventional program involved two rounds of multiplication
that each take 12 months to complete.
Although we assumed that the genetic improvement with the con-
ventional strategy is delivered to the commercial population in 3.5 years,
we assumed an additional component of genetic lag, because the genetic
merit of the sires entering the multiplier layer is “diluted” by the lagged
genetic merit of females in the multiplier layer (i.e., we assumed no
selection of females in the multiplier). Such a dilution would not occur
with the surrogate sires strategy, because themultiplication layer does not
arise. To account for this extra genetic lag in the conventional strategy we
“diluted” genetic merit of commercial sires as follows:




where at is the average genetic merit of used nucleus males in gener-
ation t and wi is the relationship coefficient between the commercial
sire and his maternal male ancestor in the generation i. We only
accounted for 6 generations with wi ranging from 0.5 in t2 1 gener-
ation to 0.015625 in the t2 6 generation. This “dilution” increased
genetic lag of the conventional strategy by an equivalent of1.04 years’
worth of extra genetic gain.
Comparison of different scenarios
To ensure that sufficient numbers of generations had been traversed for
“dilution”, we chose to present the results in terms of the genetic merit
of terminal sires used in the commercial layer emerging from
generation 11 and each subsequent generation.We report genetic merit
in units of the standard deviation of true breeding values of the nucleus
animals in the base generation (sb), i.e., as ðat 2 abÞ=sb, where at is the
average true breeding value of the nucleus males that gave rise to
commercial sires in year t and ab is the average true breeding value
of nucleus animals in the base generation. Calculating the genetic merit
of commercial sires in this way allowed the different strategies to be
compared in terms of genetic merit of the commercial sires at the same
year. Finally, we have converted the standardized genetic merit into
years’ worth of genetic gain by calculating the number of years it takes
the conventional breeding program when selecting the top 50 males to
deliver the same level of genetic merit to the commercial layer.
Data availability
Theauthors affirmthat all datanecessary for confirming the conclusions
of this article are represented fully within the article and its tables and
figures. Supplemental material available at Figshare: https://doi.org/
10.25387/g3.7442852.
RESULTS
The surrogate sires strategy increased the genetic merit of terminal sires
used in the commercial layer.The geneticmerit of commercial surrogate
sires from the surrogate sires strategy was as much as 6.5 to 9.2 years’
worth of genetic gain higher than the genetic merit of commercial sires
from the conventional multiplication strategy. In both the SmallSce-
nario and BigScenario the three-stage testing strategy was the best
strategy for identifying elite donors. The best performing three-stage
testing strategy involved a genomic test at the first stage, 100 donor
candidates tested eachwith 60 progeny at the second stage, and 20 donor
candidates tested each with 400 progeny at the third stage (see Table 1
for details). The benefit of surrogate sires strategy was greatest when
the genomic test accuracy was lowest and when the conventional
strategy required large proportions of the nucleus males to be used
for multiplication.
Inwhat follows the results are divided into three sub-sections for ease
of presentation: (i) comparison of the conventional strategy and the best
performing surrogate sires strategies; (ii) comparison of two-stage
testing scenarios of the surrogate sires strategy; and (iii) comparison
of three-stage testing scenarios of the surrogate sires strategy. To avoid
clutter in the figures or tables we do not show standard errors across the
100 replicates of the simulated scenarios because the standard errors
were small in all instances less than 0.009 YGG.
Comparison of the conventional and the best
performing surrogate sires strategies
Figure 5 and S1 show the average genetic merit of commercial sires
derived from the best performing surrogate sires strategy scenario and
the conventional strategy against time, for three different genomic test
accuracies (0.5, 0.7, and 0.9) and the SmallScenario and the BigSce-
nario. The conventional strategy used the top 50, 200, or 500 males in
multiplication. At all points in time and for all three genomic accuracies
commercial sires derived from the best performing surrogate sires
strategy scenario had a higher genetic merit than those derived from
the conventional strategy. This benefit was greater when more males
were used formultiplication in the conventional strategy. The benefit of
using surrogate sires strategy decreased as the genomic test accuracy
increased. Across time the difference between the two strategies was
almost constant. These trends were common both in the SmallScenario
and the BigScenario, although with differences in magnitude.
Table 1 enumerates some of the main results than can be observed
in Figure 4 and S1. Across all scenarios tested the best performing
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surrogate sires strategy scenario involved first a genomic test of all
donor candidates followed by two subsequent progeny tests and the
use of a single elite donor. The benefit of surrogate sires strategy
above the conventional strategy was greater when more males were
used for multiplication with the conventional strategy. When the
genomic test accuracy was low (0.5) the best strategy was to first
progeny test 100 candidates on 6,000 progeny and then to test
20 candidates on 8,000 progeny. This testing and subsequent pro-
duction of surrogate sires was assumed to take one additional year
compared to the conventional strategy. After accounting for this
extra time and for the dilution in the conventional multiplication
process, we observed that in the SmallScenario the surrogate sires
strategy delivered on average between 6.5 and 9.2 years’ worth of
extra genetic gain in commercial sires compared to the conventional
strategy that uses respectively between 50 and 500 males in multi-
plication. For the BigScenario the equivalent values were between
2.7 and 4.1 years’ worth of extra genetic gain.
When the genomic test accuracy was higher (. 0.5) the optimal
allocation of testing resources was slightly different. Instead of first
progeny testing 100 candidates, as was the case when the genomic test
accuracy was low, progeny testing 200 candidates was the best performing
scenario. All other scenario parameters were the same as when the
genomic test accuracy was low. The benefit of surrogate sires strategy
decreased with the increasing genomic test accuracy and the magni-
tude of benefit differed significantly between the SmallScenario and
the BigScenario (Table 1).
On average the surrogate sires strategy in SmallScenario delivered
between 6.5 and 9.2 years’ worth of extra genetic gain in commercial
sires when the genomic test accuracy was 0.5. When the genomic test
accuracy was 0.7 these values reduced to between 4.5 and 7.2 years and
when the genomic test accuracy was 0.9 they further reduced to
between 2.4 and 5.0 years.
On average the surrogate sires strategy in BigScenario delivered
between 2.7 and 4.1 years’ worth of extra genetic gain in commercial
n Table 1 Average Years’ worth of Genetic Gain (YGG) of the best performing surrogate sire strategy scenario above the conventional










used YGG50 YGG200 YGG500
Small Scenario
0.5 100 20 6000S1 / 8000S2 1 6.5 7.5 9.2
0.7 200 20 6000S1 / 8000S2 1 4.5 6.5 7.2
0.9 200 20 6000S1 / 8000S2 1 2.4 4.5 5.0
Big Scenario
0.5 100 20 6000S1 / 8000S2 1 2.7 3.5 4.1
0.7 200 20 6000S1 / 8000S2 1 2.1 2.5 3.5
0.9 200 20 6000S1 / 8000S2 1 1.2 1.7 2.5
1
Total number of progeny allocated in the first progeny test (S1) and in the second progeny test (S2)
Figure 5 Average genetic merit of commercial sires derived from the best performing surrogate sire strategy scenario and the conventional
strategy (top 50, 200 and 500 males) for SmallScenario (a and b) and BigScenario (c and d) plotted against time.
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sires when the genomic test accuracy was 0.5. When the genomic test
accuracy was 0.7 these values reduced to between 2.1 and 3.5 years and
when the genomic test accuracy was 0.9 they further reduced to be-
tween 1.20 and 2.50 years.
Thedifferences in the SmallScenario and theBigScenarioweredue to
the different proportions of males used in multiplication to give rise to
commercial sires. In the SmallScenario 10–100% of males were used
while the in the BigScenario 2–20% of males were used.
For simplicity of presentation andbased on the consistency of trends
described above, in the following sections we only present compari-
sons to the conventional strategy in which 50 males were used in
multiplication.
Comparison of two-stage testing scenarios of the
surrogate sires strategy
Tables 2 and 3 show the performance of different two-stage testing
scenarios of the surrogate sires strategy. Performance is measured as
the average years’ worth of extra genetic gain in the commercial sires
delivered by the surrogate sires strategy compared to the conventional
strategy for both the SmallScenario (Table 2) and the BigScenario
(Table 3). Consistent with the results reported in the previous sub-
section the benefit of surrogate sires strategy was always lower when
the genomic test accuracy was higher. In some scenarios, the benefit
was minimal. In all cases, there was an intermediate optimum for the
numbers of candidates tested. Using five elite donors was always worse
than using one. This behavior was observed in both the SmallScenario
and the BigScenario although with some interesting differences. The
BigScenario showed a general shrinkage of years’ worth of genetic gain
compared to the SmallScenario, resulting in a general increase in the
number of scenarios that showed a small benefit of the surrogate sires
strategy.
At all levels of genomic test accuracy the best scenariowas to screen
candidates based on genomic test, progeny test 112 candidates each
with 125 progeny, and use the best candidate as a single elite donor.
With the genomic test accuracy of 0.5, 0.7, and 0.9 this scenario gave
respectively 5.3, 3.6, or 2.2 years’ worth of extra genetic gain in com-
mercial sires in the SmallScenario (Table 2) and respectively 2.5, 2.0
or 1.1 years’ worth of extra genetic gain in commercial sires in the
BigScenario (Table 3).
Just as for the case of selectingone elite donor of spermatogonial cells
for surrogate sires, when selecting five elite donors, progeny testing
112 candidates eachwith 125 progeny gave the highest benefit.With the
genomic test accuracy of 0.5, 0.7, and 0.9 this scenario gave respectively
3.6, 2.6 and 1.2 years’ worth of extra genetic gain in the SmallScenario
(Table 2) and respectively 2.0, 1.1 and 1.0 in the BigScenario (Table 2).
Comparison of three-stage testing scenarios of the
surrogate sires strategy
Tables 4 and 5 shows the performance of different three-stage testing
scenarios of the surrogate sires strategy in the SmallScenario when
either one or five elite donors used. By varying several parameters,
we tested 216 (108 for the SmallScenario and 108 for the BigScenario)
different scenarios of three-stage testing with fixed total progeny testing
resources. These resources were the same as for the two-stage testing
scenarios described in the previous sub-section. The parameters with
the three-stage testing scenarios were the genomic test accuracy for the
first stage, the split of resources between the two subsequent progeny
tests, the number of tested donor candidates, the number of progeny
per tested donor candidate at each progeny test stage, and the number
of elite donors used for production of surrogate sires.
The three-stage testing gave a greater benefit than the two-stage
testing. As for the two-stage testing, using one elite donor for surrogate
sires gave a greater benefit than using five elite donors and the benefit of
surrogate sires strategy was greater when the genomic test accuracy was
lower. A total of 14,000 progeny were split across the two stages of
progeny testing. Increasing the resources in the first progeny test
increased benefit of surrogate sires strategy. For example, with the
SmallScenario when the genomic test accuracy was 0.5, 6,000 progeny
wereused in thefirst progeny test, 8,000wereused in the secondprogeny
test, and when one elite donor was used in the end, the benefit was
6.5 years’ worth of extra genetic gain in commercial sires above the
conventional strategy that uses 50 nucleus males in multiplication. This
was a greater benefit than the 5.8 years’ worth of extra genetic gain for
the scenario that split the 14,000 progeny into 4,000 for the first prog-
eny test and 10,000 for the second progeny test, which was in turn
better than the 5.4 years’ worth of extra genetic gain for the scenario
that split the 14,000 progeny into 2,000 for the first progeny test and
12,000 for the second progeny test. This trend of greater benefit when
more progeny were dedicated to the first progeny test was observed for
almost all tested scenarios.
For the SmallScenario the difference between testing 100 or 200 do-
nor candidates at the first progeny test was not consistent. That said,
when the genomic test accuracywas 0.5, allocating 100 candidates to the
first progeny test was usually better than allocating 200, and allocating
200 candidateswasusuallybetter than allocating400.Athigher genomic
test accuracies, therewere little differences betweenallocating100or200
n Table 2 Average Years’ worth of Genetic Gain (YGG) with the two-stage testing scenarios of
the surrogate sire strategy above the conventional strategy that uses 50 males (SmallScenario)
Males Tested Progeny/Male Donors used YGG0.51 YGG0.71 YGG0.91
14 1000 1 4.1 3.0 1.8
28 500 1 4.7 3.0 1.2
56 250 1 5.1 3.5 2.2
112 125 1 5.3 3.6 2.2
224 63 1 4.8 2.8 1.3
448 31 1 3.8 2.1 1.1
14 1000 5 2.9 1.9 0.2
28 500 5 3.1 2.1 0.5
56 250 5 3.6 2.4 1.1
112 125 5 3.6 2.6 1.2
224 63 5 3.4 1.9 0.3
448 31 5 2.8 1.6 0.2
1
Genomic test accuracy at the initial stage (S0) 0.5, 0.7, and 0.9.
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candidates to thefirst progeny test, butbothof these sets of scenarioswere
usually better than allocating 400 candidates to the first progeny test.
In the SmallScenario allocating 20 elite donor candidates to the
second progeny test was almost always better than allocating 10 can-
didates. A total of 54 scenarios were evaluated for SmallScenario. In
only 6 of these scenarios allocating 10 candidates was better than
allocating 20.
Overall for the SmallScenario, when the genomic test accuracy was
0.5, the best three-stage testing scenario used 6,000 progenies in the first
progeny test of 100 candidates eachwith 60 progeny, 8,000 progenies in
the second progeny test of 20 candidates each with 400 progeny, and
useda single elitedonor for surrogate sires.This scenariogaveabenefit of
6.50 years’ worth of extra genetic gain in commercial sires compared to
the conventional strategy. The same distribution of testing resources
was also the joint best when five, instead of one, elite donors were used
for surrogate sires.
The same trends as for the SmallScenario were observed also for the
BigScenario, but with smaller benefit of the surrogate sire strategy (See
table S1 and S2).
DISCUSSION
Theresultsof thispaper suggest thatasurrogate sires strategycouldbevery
beneficial for the dissemination of genetic gain in animal breeding. In
summary, our results indicate that benefits of the as much as 6.5 to 9.2
years’ worth of genetic gain in commercial sires could be realized with
surrogate sires compared to the conventional multiplication. It was best
to identify elite donors for surrogate sires via a three-stage testing strategy
involving a first screen with a genomic test followed by two subsequent
progeny tests. The benefits of a surrogate sires strategy were greater when
genomic test accuracywas low andwhen the conventional strategy used a
large proportion of males in multiplication. To discuss these results we
divide the discussion into four sections: (i) possible explanations for the
observed trends; (ii) justification and impact of assumptions; (iii) the
potential impact of surrogate sires on the redesign of animal breeding
programs; and (iv) risks and opportunities of using surrogate sires.
Possible explanations for the observed trends
That surrogate sire technology generates such a benefit in terms of years’
worth of genetic gain can be explained in the context of the breeders’
n Table 3 Average Years’ worth of Genetic Gain (YGG) with the two-stage testing scenarios of
the surrogate sire strategy above the conventional strategy that uses 50 males (BigScenario
Males Tested Progeny/Male Donors used YGG0.51 YGG0.71 YGG0.91
14 1000 1 2.3 1.7 0.7
28 500 1 2.4 1.9 0.8
56 250 1 2.5 2.0 1.0
112 125 1 2.5 2.0 1.1
224 63 1 2.0 1.8 0.8
448 31 1 1.9 1.5 0.4
14 1000 5 1.7 1.2 0.5
28 500 5 1.7 1.2 0.7
56 250 5 1.9 1.1 1.0
112 125 5 2.0 1.1 1.0
224 63 5 1.8 1.0 0.5
448 31 5 1.0 0.8 0.3
1
Genomic test accuracy at the initial stage (S0) 0.5, 0.7, and 0.9.
n Table 4 Average Years’ worth of Genetic Gain (YGG) with the three-stage testing scenarios of the surrogate sire strategy with one elite




tested S1 Progeny/Male S1
Males progeny
tested S2 Progeny/Male S2 YGG0.52 YGG0.72 YGG0.92
2000S1/12000S2 100 20 10 1200 5.3 3.5 2.2
20 600 5.4 3.6 2.4
200 10 10 1200 4.9 3.2 2.2
20 600 5.1 3.3 2.1
400 5 10 1200 4.5 3.7 2.0
20 600 4.7 2.7 1.4
4000S1/10000S2 100 40 10 1000 5.5 3.6 2.2
20 500 5.8 4.0 2.3
200 20 10 1000 5.3 3.5 2.4
20 500 5.4 3.8 2.3
400 10 10 1000 4.3 3.3 1.6
20 500 4.5 3.5 1.4
6000S1/8000S2 100 60 10 800 5.9 4.1 2.0
20 400 6.5 4.2 2.2
200 30 10 800 5.3 4.2 2.1
20 400 5.7 4.5 2.4
400 15 10 800 5.0 3.4 1.6
20 400 5.8 3.5 1.2
1
Number of total progeny allocated in the first progeny test (S1) and in the second progeny test(S2)
2
Genomic test accuracy at the initial stage (S0) 0.5, 0.7, and 0.9.
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equation.While the surrogate sires strategy does not rely on the selection
of the best individuals and using them as parents of the next generation, it
does rely on the identification of the best individuals from a cohort and
using them as donors of spermatogonial cells for surrogate sires, which is
another form of the selection problem. In any cohort, the best few indi-
viduals will be some number of standard deviations above the cohort
average. For example, when surrogate sires technology delivered 6.5 years’
worth of additional genetic gain in commercial sires the best nucleusmale
was on average 2.7 standard deviations above the cohort mean. In con-
trast, the best 50 nucleus males were 2.0 standard deviations above the
cohort mean. Given that the breeding program proceeded at a rate of
genetic progress of 0.4 standard deviations per year, choosing the best
male as a donor for surrogate sires rather than the best 50males produced
surrogate sires that were better for more than 8 years’ worth of genetic
gain. However, accounting for the imperfect accuracy of identifying do-
nors with the surrogate strategy or the best 50 males for multiplication
with the conventional strategy and the time to generate commercial sires
with either strategy the final result was 6.5 years’ worth of genetic gain.
With constant progeny test accuracies the benefit of the surrogate
sires strategy depended on the proportion of male candidates that the
conventional strategy used to give rise to commercial sires. If the
breeding program needed to use a large proportion of its nucleus male
candidates (e.g., the best 200 or 500) the benefit of surrogate sires
strategy was greater than if it needed to use a few. Again, this result
is entirely consistent with the breeders’ equation. Specifically, it can be
explained in the context of selection intensity being a nonlinear func-
tion of the percentage of selected individuals, i.e., selection intensity
increases almost linearly down to 20 or 10% selected, but increases
sharply (nonlinearly) thereafter. While both conventional and surro-
gate sires strategies exploit the tail of distribution with high selection
intensities, the surrogate sires strategy also exploits the steeper part.
This explains why the benefit of surrogate sires was higher in the
SmallScenario than in the BigScenario. In the SmallScenario we had
500 candidates and selected 100 with the conventional strategy (per-
centage selected 20% and selection intensity 1.4) or 1 with the surrogate
sires strategy (percentage selected 0.2% and selection intensity 3.2).
In the BigScenario we had 2,500 candidates and selected 100 with the
conventional strategy (percentage selected 4% and selection intensity
2.2) or 1 with the surrogate sires strategy (percentage selected 0.04%
and selection intensity 3.6). The same logic also explains why selecting
five as opposed to one donor for surrogate sires gave a lower benefit.
The observed differences in the performance of different surrogate
sire strategies can also be explained in the context of the breeders’
equation. When the genomic test accuracy used in the first stage of
testing was lower the benefit of surrogate sires strategy was higher.
Under the conventional strategy, the average genetic merit of the nu-
cleus males that gave rise to commercial sires was lower when the
genomic test accuracy was lower than when it was higher. With surro-
gate sires strategy this reduction in genetic merit due to the low geno-
mic test accuracy is compensated by the subsequent progeny tests. This
is in line with the analysis of Dickerson and Hazel (Dickerson and
Hazel 1944), who compared the use of progeny test as a supplement
to earlier culling on own or sibling performance. Their conclusion was
that progeny testing is warranted when heritability is low in which case
accuracy of estimated breeding values from own or sibling phenotypes
(or genomic prediction in our study) is low. Genomic selection can be
thought of as a light touch first screen, the purpose of which is to
identify the top group of animals, which are then tested on many
progeny. The purpose of subsequent progeny tests is then a search
for the best individual within this group.
This same logic also explains why the three-stage testing was
better than the two-stage testing. Both schemes started with a
genomic test that was followed by one progeny test with the two-
stage testing or two subsequent progeny tests with the three-stage
testing.With the three-stage testing thefirst progeny test serves to use
a portion of resources to evaluate many candidates relatively accu-
rately in order to discard most candidates. Then the second progeny
test uses the remaining resources to evenmore accurately identify the
final candidate. In terms of the breeders’ equation the first progeny
test maximizes selection intensity, while the second maximizes ac-
curacy. The three-stage testing appears to address both of these
parameters more optimally than the two-stage testing.
n Table 5 Average with the three-stage testing scenarios of the surrogate sire strategy with five elite donors above the conventional




tested S1 Progeny/Male S1
Males progeny
tested S2 Progeny/Male S2 YGG0.52 YGG0.72 YGG0.92
2000S1/12000S2 100 20 10 1200 4.1 2.1 1.1
20 600 4.4 2.2 1.2
200 10 10 1200 3.0 2.1 1.2
20 600 3.7 2.5 1.3
400 5 10 1200 2.2 1.5 1.0
20 600 2.2 1.4 1.0
4000S1/10000S2 100 40 10 1000 4.4 2.4 1.3
20 500 4.5 2.5 1.2
200 20 10 1000 4.1 2.2 1.1
20 500 4.1 2.7 1.2
400 10 10 1000 4.2 1.7 1.0
20 500 4.2 2.0 1.8
6000S1/8000S2 100 60 10 800 4.5 3.1 1.6
20 400 5.0 3.2 1.8
200 30 10 800 4.6 2.1 1.3
20 400 5.0 2.2 1.4
400 15 10 800 4.1 1.7 1.2
20 400 4.6 2.2 1.2
1
Number of total progeny allocated in the first progeny test(S1) and in the second progeny test(S2)
2
Genomic test accuracy at the initial stage (S0) 0.5, 0.7, and 0.9.
Volume 9 January 2019 | Surrogate Sire Technology | 211
There is a substantial body of literature on multi-stage selection
(Cunningham 1975; Saxton 1983; Ducrocq and Colleau 1989; Xie et al.
1997; Mi et al. 2014) which the observed trends in this study are
consistent with. It is well known that increasing the number of progeny
per candidate increases accuracy (Robertson 1957; Meuwissen and
Goddard 1997) and that the number of candidates to be tested is
important and the trade-off between the two must be found. In our
simulations, we found the optimum at progeny testing 112 candidates,
given a fixed amount of resources, in our case 14,000 progeny. This
optimum was consistent across the different levels of genomic test ac-
curacy. However, the level of genomic test accuracy heavily influenced
the amount of extra genetic gain, because higher accuracy directly trans-
lates to higher genetic gain. These trends are consistent with the long-
established multi-stage testing in plant breeding (Visscher et al. 2000).
Most plant breeding programs use multi-stage testing to identify elite
single genotype (e.g., inbred line) that is then deliver to the commercial
layer. Typically, these programs initially screen many individuals impre-
cisely at the first stage. At each subsequent stage they reduce the number
of tested individuals, but the testing precision is increased.
Justification and impact of assumptions
There is a huge range of possible strategies for the identification of
donors for surrogate sires and we only evaluated a small subset in this
study. We choose the tested range of scenarios because we believe they
could demonstrate the properties of surrogate sires strategy. They show
that in somecircumstances surrogate sires candeliver a large benefit and
inothers smallbenefit.Wechose the three levelsofgenomic testaccuracy
as these levels reflect what might be possible in breeding programs of
various sizes. To ensure that all strategies used an equal set of resources
we set the total number of progeny involved inprogeny testing to14,000.
We chose this number as it was divisible in many ways and thereby
enabled several strategies to be compared and because this number was
similar the 10,000 progeny that would be used by an animal breeding
program that each year tested 100 candidates each with 100 progeny, a
scale of progeny testing that was not uncommon in some animal
breeding programs before the advent of genomic selection.
With the two-stage testing the total testingresourcesweredistributed
across many or few candidates. As expected, testing an intermediate to
highnumber of candidates (i.e., 112 to 224) on a relatively small number
of progeny (i.e., 125 to 63) gave higher benefits than testing a few
candidates (e.g., 14) on many progeny or a very high number of can-
didates (448) on few progeny (31). These trends fit the expectations
from the breeders’ equation and occur due to the interplay between
selection intensity and accuracy. However, when the chosen elite do-
nors of spermatogonial cells for surrogate sires are to be used to pro-
duce huge numbers of progeny in the commercial layer, the risk of a
donor carrying somemajor defect that was not identified by the testing
process must also be minimized. For this reason, it is unlikely that a
strategy in which donors are testedwith a single stage of progeny testing
using a 200 or less progeny would ever be used by a commercial
breeding program.
It was this logic that motivated us in our design of the three-stage
testing scheme. Our intuition was that the first progeny test would
evaluatemany candidates with relatively low accuracy, while the second
progeny testwould evaluate a handful of individualswith high accuracy,
i.e., 10 or 20 candidates each with respectively 800 or 400 progeny.
Using many progeny ensures high accuracy, but also a high degree of
certainty that the final donor(s) would not carry any major defects.
A major assumption of this study was the amount of time it took to
identify elite donors and then tomake surrogate sires. It is likely that the
different time assumptions could be shortened or lengthened for both
the conventionalmultiplication strategy and the surrogate sires strategy
in several ways and depending on the assumed species. The benefit of
surrogate sires strategy would change accordingly.
Finally, we choose to model a pig breeding program in this study
because this is the species that we are most familiar with. The benefits
may be greater or smaller for other species. The benefits depend on the
ratio of existing reproductive rates ofmales vs. that enabled by surrogate
sire technology, the time and cost associated with performing progeny
tests, the levels of accuracy that can be obtained by genomic prediction
and the relative cost and technical possibilities of surrogate sire tech-
nology itself in a particular species. Incidentally, in this study we did not
account for the cost aspects of surrogate sire technology itself. Un-
doubtedly developing the technology itself will be hugely expensive
and these costs of development may impact its eventual commercial
cost. That said, in time many biotechnologies which are initially ex-
pensive become much cheaper (e.g., nowadays genotyping and animal
cloning are both relatively inexpensive compared to their former costs)
and we anticipate that surrogate sire technology will follow a similar
pattern. However, given we have ignored the cost component of sur-
rogate sire technology its benefit may be overestimated based on our
results compared to a study which would account for such costs.
The potential impact of surrogate sires on the redesign
of animal breeding programs
Animal breeding programs maximize the genetic merit of commercial
animals within the available financial, physical, technical, and physio-
logical constraints. Implicitly a breeding program has two objectives:
(i) improving themeanof thepopulation; and (ii) deliveringaproduct to
the commercial producers. In dairy cattle for example, before the advent
of genomic selection, breeders used progeny testing schemes that in-
tensivelyevaluated relatively small numbersof candidatemales andused
the best of these as parents to improve the population, but also as a
commercial andbreedingproduct tobe usedby the commercial layer. In
doing so, dairy cattle breeders maximized selection accuracy, but were
constrained in their ability to increase selection intensity and decrease
generation interval. However, commercial producers used well tested
sires and therefore an individual producer could rely on using relatively
fewsires,who togethercould serveentiregeographic regions.Theadvent
of genomic selection changed this paradigm. Under genomic selection
progeny testing of a small numberof candidates hasbeen replacedwith a
genomic testing of a large number of candidates. Those with best
predictions are used as parents to improve the “open” nucleus popu-
lation, but are also sold to commercial layer as a team of sires product
(i.e., a group of sires sold together rather than a single sire sold on its
own). In doing so, dairy cattle breeders increased selection intensity and
reduced generation interval, but are constrained in their ability to
achieve very high accuracy. Given that each candidate male has not
had their merit assessed based on phenotypes of their progeny, there is
a risk that certain sires are not that good or may carry mutations that
are highly detrimental (e.g., a de-novo mutation that prevents progeny
from lactating) (Milan et al. 2000; VanRaden et al. 2011; Kadri et al.
2014). To overcome this risk, breeders recommend that commercial
producers use semen of a larger number (i.e., a team) of sires and limit
their use of any one sire.
A surrogate sires strategy would need to exploit aspects of both
genomic and progeny testing. Genomic testing can be used to drive the
population improvement and, as demonstrated in the present paper, to
identify a set of candidates that could enter a progeny testing scheme as
part of the product development. The role of the progeny testing is to
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ensure that the chosen elite donors that give rise to surrogate sires
released to the commercial sector are good animals, that they are not
significantlyworse than it is predicted by a genomic test and that theydo
not carry detrimental mutations. As demonstrated by the results of the
present study two subsequent progeny tests used resources more
efficiently than a single progeny test. Such multi-stage testing has a
long history of use in plant breeding which also has a long history
delivering products to commercial producers in a way that is highly
analogous to what surrogate sires would enable for animal producers.
The majority of commercial producers for all of the major crops
(maize, wheat, rice) use inbred lines or their hybrids. These inbred or
hybrid lines can be grown on huge areas. Plant and animal breeding
designs have diverged somewhat over the years owing to differences in
biology, economics, and technical possibilities. Surrogate sire technol-
ogy, combined with genomic selection, could result in a coalescence of
designs across plant and animal breeding. One such design that could
apply to both is the two-part scheme recently proposed by Gaynor et al.
(2017)(Gaynor et al. 2017). In this scheme, rapid recurrent selection
based on genomic testing is used to increase the mean of the popula-
tion, while multi-stage testing (genomic and phenotypic) is used to
periodically extract, test, and develop a product from the population.
The population improvement component resembles the nucleus of
animal breeding programs, while the product development component
resembles the multi-stage testing to derive inbred or hybrid lines of
plant breeding programs. The latter could also be seen as an improved
multiplication layer of animal breeding programs that exploit breed
complementarity to deliver a commercial product.
In the present work, we focused on the use of surrogate sires to
produce commercial animals (e.g., a terminal sire in a pig population).
To do this, donors for surrogate sires were chosen based on their
general combining ability. The strategy could also be extended to ex-
ploit specific combining ability to produce a relatively homogenous set
of females from a maternal line that are crossed with single terminal
male (via surrogate sires). Use of specific combining ability is wide-
spread in hybrid crops where it exploits complementarity of pairs of
individuals and heterosis generated by specific pairs of individuals. The
surrogate sires strategy proposed in the present paper could be ex-
tended to exploit specific combining ability by adding additional stages
that progeny tests specific crosses as is conducted in hybrid plant
breeding programs. Because in livestock the parents are outbred (com-
pared to crops where they are often inbred), a tiered strategy may be
needed in the maternal line(s) that homogenizes dam haplotypes. For
example, using a single surrogate sire, grandsire, and great-grandsire on
thematernal population would give a pool of females that carried one of
two haplotypes for 87.5% (0.5 + 0.25 + 0.125) of their genome. The
terminal surrogate sire would be chosen based on a specific combining
ability to these haplotypes.
Risks and opportunities of using surrogate sires
Surrogate sires present risks and opportunities to commercial pro-
duction. The most obvious risk relates to the genetic homogeneity of
commercial animals if a single surrogate sire, or a set of very closely
related surrogate sires were used. If a disease emerged that this homog-
enous group of animals was susceptible to, it could have a major
detrimental impact on the commercial production. Having such large
groups of homogeneous animals would also increase the selection
pressure on disease pathogens to evolve pathogenicity to the group.
Plant breeders and commercial crop growers have extensive experience
in managing the potential to have genetic homogeneity across large
segments of the production area. They have developed strategies
to minimize the risk of disease outbreaks and other failures such
as crop rotation, using multiple varieties on a farm, creating varietal
blends consisting ofmultiple genotypes, and taking holistic strategies
to pathogen management (McDonald and Linde 2002). Aside from
rotation, which is practically impossible in the animal sector, these
strategies might have important roles in ensuring the effectiveness
of surrogate sires in livestock.
A further risk of the homogenization of the commercial population
relates to genetic diversity. The genetic diversity contained in current
populations is potentially a useful reserve of genetic diversity that could
be used in breedingprograms in case the nucleus genetic diversitywas to
become inappropriate at some point in the future (e.g., due to a disease
catastrophe or because it became exhausted). Homogenization of the
commercial population would remove this safety net requiring greater
care to be taken in the preservation of genetic diversity. Genebanks
using frozen semen, eggs, or embryos are well established ways to pre-
serve genetic diversity. There are also newways which include the use of
cultured primordial germ cells (Nandi et al. 2016).
Undetected but highly deleterious mutations also pose a risk for the
use of surrogate sires. While it is unlikely that this would arise after
sufficient testing, it is not impossible. One such route could be through
the occurrence of one or more such mutations arising as somatic
mutations after the animal had been tested, leading to a mosaicism,
which might affect sets of surrogate sires from the donor.
The most obvious opportunity emanating from surrogate sires also
relates to the genetic homogeneity of commercial animals and can
also draw on practices that are well established in crop production. In
crops, management plans are supplied to a farmer alongside the seed
(e.g., https://catalog.extension.oregonstate.edu/em9004). These plans
are specifically tailored to the variety genotype based on extensive sets
of field trials. They include recommendations for target market,
expected performance, optimum sowing date, seeding rate, soil type
and water, fertilizer, pesticide and fungicide requirements. These man-
agement plans complement the genetics of the variety and increase the
benefit obtained from the genetic potential in a generic environment.
Similar management plans could be developed for surrogate sires and
the benefits would be similarly expected to exceed the benefit that was
observed in the present study for the genetics alone (e.g., 6.5 year’s
worth of genetic gain). The phenotype data collected to development
of the management plans would also serve to further test and validate a
particular donor.
Another obvious opportunity emanating from surrogate sires that
also relates to the genetic homogeneity is the potential for increasing the
product homogeneity. In animal production, product uniformity is an
important topic. Inmeat animals, for instance, uniformity has economic
benefits because excessive variability in carcass weight or conformation
is penalized by slaughterhouses (Mulder et al. 2007;Mulder et al. 2008).
A genetically homogeneous commercial population, achieved through
the use of surrogate sires, could aid product uniformity. However, if this
was to be achieved, most of the increase in uniformity would need to
emanate frommatching very specific management plans to the homog-
enous genetics because homogeneous genetics in itself has limited abil-
ity to increase phenotypic homogeneity. Van Vleck (van Vleck 1999)
showed that in the context of cloned animals, if heritability is 25%, then
the phenotypic standard deviation among clones would be 87% of that
of uncloned animals and only if heritability is 100%, will clone mates
have complete uniformity.
Compared to the conventional multiplication the surrogate sires
strategy enables shorter lag between nucleus and commercial layer and
requires a smaller number of parents contributing to the commercial
layer. This offers several advantages including the ability to rapidly
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change the entire genetics in the commercial layer. This could be used to
rapidly respond to sudden changes in requirements such as pressure
fromanewdiseaseor the emergenceofanewmarket for theproduct that
has specific requirements (e.g., meat marbling).
The surrogate sire strategy would be costly to implement in
practice because it would require capacity in advanced molecular
biology and infrastructure for progeny testing. However, it presents
other opportunities through which costs can be saved. For example,
multiplier populations to produce terminal sires would not need to
be maintained. This would free up resources for other investment
in breeding programs, such as more progeny testing of donor
candidates.
The surrogate sires strategy presents breeding programs with an
enhanced opportunity to protect its intellectual property via limited
release of males (thereby limiting the access of competitors to the
broader source germplasm) and by exploitation of specific combin-
ing ability. This protection would give the breeding companies
incentive to invest more and help to avoid the commonly observed
market failure in some breeding industries. When intellectual prop-
erty is properly protected, breeding companies are anecdotally
reported to share the benefits two-thirds to the farmers and one
third to the breeding company. Such sharing more than offsets the
purchase cost to a producer, while it also gives profit to the breeder.
Perhaps the most spectacular example of the benefits of such ways to
reward investment in intellectual property are seen in maize which
has seen a sixfold increase in productivity since hybrid breeding was
introduced in the 1930s (Duvick 2005). By releasing hybrids breed-
ing organizations can protect the intellectual property that is their
source germplasm. This in turn enables them to invest heavily in
breeding activities (e.g., technology, field testing networks) that in
turn drive accelerated genetic gains.
At least two barriers exist that may prevent the deployment of this
technology in in real livestock breeding program. First, genome editing
currently appears to be the technology that is most likely to enable
genome editing to be implemented in practice (Oatley 2017). Globally,
the future of governmental regulation of genome editing technology is
currently uncertain which places uncertainty on the possibility for
practical implementation of surrogate sire technology in real livestock
breeding program. Second, effective deployment of surrogate sire tech-
nology will require partitioning of animal breeding programs into
population improvement and product development parts. Product
development will require deployment of extensive progeny testing
schemes. Over the past decade the advent of genomic selection has
removed progeny testing schemes from many breeding programs.
Reinstating such schemes would be costly and further work will be
needed to demonstrate the exact return on investment.
Finally, the results of this study raise an important question for
existing breeding programs that use artificial insemination for dissem-
ination. As noted above, genomic selection has led to the removal of
progeny testing schemes from many livestock breeding programs. Our
results raise some doubts about themerit of this. They show that when a
breeding program releases a small number of individuals that are
deployed widely there is a benefit to progeny testing these individuals.
The degree of benefit depends on the accuracy of genomic selection,
the number of individuals released and their subsequent usage, and
the accuracy and the number of stages in a progeny testing scheme
and the relative time taken to perform a progeny test. Determining
whether the removal of progeny testing schemes from genomic
selection driven livestock breeding programs was the right thing
to do in retrospect is beyond the scope of the present study but is an
interesting question for future research.
Conclusions
The results of this study showed that using the surrogate sires strategy
could significantly increase the genetic merit of commercial sires, by
as much as 6.5 to 9.2 years’ worth of genetic gain, compared to the
conventional multiplication strategy. The simulations suggest that
identifying elite donors for surrogate sires should be based on three
stages, the first of which uses a genomic test followed by two subsequent
progeny tests. The use of one or a handful of elite donors to generate
surrogate sires that in turn give rise to all production animals would be
very different to current practice. While the results demonstrate the
great potential of surrogate sires strategy there are considerable risks as
well as opportunities. Practical implementation of surrogate sires strat-
egy would need to account for these.
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